By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein structure analysis firm Proteros today announced a deal with the University of Cincinnati, Drug Discovery Center to provide biotechnology and drug firms access to UC DDC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

Proteros, based in Martinsried, Germany, will serve as a single point of contact and be responsible for all client interactions and project management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.